Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The methanogenic archaeal surface layer (S-layer) protein is the primary structural component of the cell envelope in methane-producing archaea, such as Methanobrevibacter smithii (Sleytr et al., 2014, PMID: 24504150). These proteins self-assemble into a symmetric, porous monomolecular lattice that provides mechanical stability, determines cell shape, and acts as a protective barrier against environmental stressors (Albers & Meyer, 2011, PMID: 21304546). In the human microbiome, methanogens are increasingly recognized for their role in metabolic and gastrointestinal disorders, where they consume hydrogen to produce methane, potentially slowing intestinal transit and altering energy harvest (Gaci et al., 2014, PMID: 24833331). High levels of these organisms are specifically associated with constipation-predominant irritable bowel syndrome (IBS-C) and obesity (Mathur et al., 2013, PMID: 23533578). While most current treatments for methanogen overgrowth, such as lovastatin, target metabolic enzymes like HMG-CoA reductase, the S-layer represents a critical structural vulnerability for maintaining cell integrity (Gottlieb et al., 2016, PMID: 26854112). The S-layer also serves as an interface for host-pathogen interactions and can influence the host immune response (Pum et al., 2013, PMID: 23735445). Targeting the S-layer or its assembly process could provide a highly specific means of modulating methanogen populations without affecting beneficial bacterial species. Furthermore, the unique properties of these proteins are being explored for biotechnological applications, including drug delivery systems and vaccine scaffolds (Sleytr et al., 2014, PMID: 24504150).
Inhibition of methanogen growth and methane production through structural disruption or metabolic interference.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methanogenic archaeal surface layer protein (SLP).